HANSA BIOPHARMA

hansa-biopharma-logo

Hansa Biopharma is an innovative and rapidly growing biopharmaceutical company that leverages its unique enzyme technology.

#SimilarOrganizations #People #Financial #Website #More

HANSA BIOPHARMA

Social Links:

Industry:
Biotechnology Health Care

Founded:
2007-01-01

Address:
Lund, Skane Lan, Sweden

Country:
Sweden

Website Url:
http://www.hansabiopharma.com

Total Employee:
51+

Status:
Active

Contact:
46 46 16 56 70

Email Addresses:
[email protected]

Total Funding:
70 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Font Awesome Nginx Microsoft Exchange Online


Similar Organizations

marinomed-logo

Marinomed

Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.

Current Employees Featured

donato-spota_image

Donato Spota
Donato Spota CFO @ Hansa Biopharma
CFO
2019-05-01

not_available_image

Join Hansa
Join Hansa Founding Member @ Hansa Biopharma
Founding Member

achim-kaufhold_image

Achim Kaufhold
Achim Kaufhold Chief Medical Officer @ Hansa Biopharma
Chief Medical Officer
2020-06-01

Founder


not_available_image

Join Hansa

Stock Details


Company's stock symbol is STO:HNSA

Investors List

novaquest-capital-management_image

Novaquest Capital Management

Novaquest Capital Management investment in Grant - Hansa Biopharma

Official Site Inspections

http://www.hansabiopharma.com Semrush global rank: 4.08 M Semrush visits lastest month: 3 K

  • Host name: 52.174.176.76
  • IP address: 52.174.176.76
  • Location: Amsterdam Netherlands
  • Latitude: 52.3534
  • Longitude: 4.9087
  • Timezone: Europe/Amsterdam
  • Postal: 1091

Loading ...

More informations about "Hansa Biopharma"

About Hansa Biopharma

Our values. At Hansa Biopharma, we strive to create an inclusive environment that embraces difference and fosters inclusion. We believe that valuing diversity and inclusion will create an environment in which all talent can grow and our โ€ฆSee details»

Hansa Biopharma - Crunchbase Company Profile & Funding

Hansa Biopharma is a biopharmaceutical company that develops immunomodulatory treatments for people living with rare immunological diseases. They concentrate on creating novel, life โ€ฆSee details»

Hansa Biopharma publishes 2023 Annual and Sustainability Reports

Lund, Sweden, March 21, 2024. Hansa Biopharma AB, โ€œHansaโ€ or the โ€œCompanyโ€ (Nasdaq Stockholm: HNSA), today announced the publication of its 2023 Annual and Sustainability โ€ฆSee details»

Hansa Biopharma - Overview, News & Similar companies - ZoomInfo

Hansa Biopharma contact info: Phone number: (312) 386-8200 Website: www.hansabiopharma.com What does Hansa Biopharma do? Founded in 2007, Hansa โ€ฆSee details»

Hansa Biopharma AB | VentureRadar

Similar Companies: Hansa Medical AB Sweden n/a Hansa Biopharma AB (NASDAQ Stockholm:HNSA) is harnessing its proprietary immunomodulatory enzyme technology โ€ฆSee details»

Hansa Biopharma - Craft

Oct 29, 2024 Hansa Biopharma has 5 employees at their 1 location and kr134.09 m in annual revenue in FY 2023. See insights on Hansa Biopharma including office locations, competitors, โ€ฆSee details»

Hansa Biopharma AB Company Description - Stock Analysis

Nov 12, 2024 Company profile for Hansa Biopharma AB (publ) (STO: HNSA) with a description, list of executives, contact details and other key facts.See details»

Hansa Biopharma plans restructuring to strengthen long-term ...

Dec 5, 2023 E: [email protected] About Hansa Biopharma Hansa Biopharma is a pioneering commercial-stage biopharmaceutical company on a mission to โ€ฆSee details»

Hansa Biopharma : Genethon and Hansa Biopharma

3 days ago The company is listed on Nasdaq Stockholm under the ticker HNSA. Find out more at www.hansabiopharma.com and follow us on LinkedIn. About Genethon. A pioneer in the โ€ฆSee details»

People - Hansa Biopharma

Hansa Biopharma and selected partners use cookies and similar technologies to ensure you get the best experience on this website. If you consent to it, we will use cookies for analytics โ€ฆSee details»

Hansa Biopharma AB: Genethon and Hansa Biopharma announce โ€ฆ

3 days ago Stephanie Kenney, VP Global Corporate Affairs [email protected] GENETHON Stéphanie Bardon [email protected] +33 (0) 6.45.15.95.87 Notes to โ€ฆSee details»

Hansa Biopharma publishes Annual Report 2022

Lund, Sweden, March 30, 2023 Hansa Biopharma AB โ€œHansaโ€ (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced the release โ€ฆSee details»

Hansa Biopharma is stepping up their portfolio and project โ€ฆ

Nov 30, 2023 It will be exciting to follow Hansa Biopharma's progress as they develop and streamline their portfolio and project operations within their organization. Hansa is a โ€ฆSee details»

Hansa Biopharma publishes Annual Report 2020

Lund, Sweden April 8, 2021 Hansa Biopharma AB โ€œHansaโ€ (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced the release of the โ€ฆSee details»

Genethon and Hansa Biopharma announce initiation of a Phase 2 โ€ฆ

3 days ago The company is listed on Nasdaq Stockholm under the ticker HNSA. Find out more at www.hansabiopharma.com and follow us on LinkedIn. About Genethon. A pioneer in the โ€ฆSee details»

Jobs list - Hansa Biopharma

Hansa Biopharma and selected partners use cookies and similar technologies to ensure you get the best experience on this website. If you consent to it, we will use cookies for analytics โ€ฆSee details»

Hansa Biopharma Launches Phase 2 Trial for Gene Therapy โ€ฆ

3 days ago Find out more at www.hansabiopharma.com and follow us on LinkedIn. About Genethon. A pioneer in the discovery and development of gene therapies for rare diseases, โ€ฆSee details»

Hansa Biopharma AB certified as a Great Place to Work [® ]

Sep 11, 2020 Everything they do is driven by the mission to build a better world by helping every organization become a Great Place to Work For Allโ„ข. To learn more, visit โ€ฆSee details»

Hansa Biopharma achieves Great Place to Work® certification for โ€ฆ

Lund, Sweden, September 30, 2022. Hansa Biopharma AB, โ€œHansaโ€ (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare immunological conditions, today announced its โ€ฆSee details»

linkstock.net © 2022. All rights reserved